GRIDD tackles devastating diseases using the unique Compounds Australia and Nature Bank resources, and an extensive global network of partners.
We innovate at the chemistry-biology interface, and collaborate with academia, the community, government, health, not-for-profits and industry. We thank our supporters including the Clem Jones Foundation, Perry Cross Spinal Research Foundation, Aegium, Parkinson’s Queensland, and the Queensland and Australian Governments.
We are proud to foster the next generation of drug discovery scientists.
Please partner with us in our search for revolutionary new treatments.
The Institute strives for excellence through supporting our research teams to work collaboratively to advance the discovery of new drugs. Innovation is encouraged through cross-disciplinary rigour and global collaboration. Read more about our work combating specific diseases and disabilities, below.
Directions in Drug Discovery
An estimated 130,470 new cases of cancer were diagnosed in Australia in 2016, with that number set to rise to 150,000 by 2020. Professors Vicky Avery, Sally-Ann Poulsen and Associate Professor Rohan Davis are working to discover compounds that are active against breast, prostate and pancreatic cancer.
Infectious diseases kill more than one million people annually. GRIDD’s Professors Kathy Andrews, Vicky Avery and Ronald Quinn are seeking new drugs to treat diseases like malaria and TB, while Director Professor Jenny Martin is exploring new approaches to treat complicated urinary tract infections as well as melioidosis, a common disease in northern Australia.
About 70,000 Australians are affected by this progressive disease of the nervous system. Professor George Mellick’s research explores the genetics of Parkinsonism and the interactions between genetic and environmental factors that contribute to onset and development of the disease.
Professor Sally-Ann Poulsen has discovered a new way to reverse multidrug resistance in cancer. While Director Professor Jenny Martin is exploring how to disarm bacteria so they cannot cause disease.
Spinal Cord Injury Repair
Up to half a million people globally suffer from spinal cord injury. GRIDD’s Dr James St John in the Clem Jones Centre for Neurobiology and Stem Cell Research offers hope of new therapies. This research was pioneered by 2017 Australian of the Year, Professor Emeritus Alan Mackay-Sim.
Stay up to date
We are supported by a growing number of sponsors who share our vision for the future
May 22, 2017
Griffith University researcher recognised as one of Australia’s leading scientists
Internationally renowned protein crystallographer Professor Jennifer Martin is one of 21 scientists who have been elected to the Australian Academy of Science, a rare and esteemed honour, for their outstanding contributions to science. The Director of the Griffith Institute for Drug Discovery (GRIDD) has made seminal discoveries in bacterial redox biochemistry, including revealing how the […]
May 16, 2017
Scientists share STEM in children’s books!
Griffith University scientists hope to encourage more students into science, technology, engineering and mathematics (STEM) through the creation of engaging children’s books. Griffith’s That’s Rad! Science project was among 28 new ‘diverse and exciting’ Advance Queensland Engaging Science Grants recipients, sharing in almost $270,000 to increase STEM skills and engagement. The project will support the creation […]
May 10, 2017
Griffith secures $5m to help cure spinal cord injury
The Queensland Government has invested $5 million in a Griffith University pre-clinical trial to prove that a “nerve bridge” across a damaged spinal cord may be the answer to otherwise permanent paralysis. In a science and health collaboration, the project, led by Dr James St John, will be conducted across two of the university’s leading […]